Get startedLog in
    Picture of POINT Biopharma Global logo

    PNT — POINT Biopharma Global News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid Cap
    All News

    Brief: POINT Biopharma - As Of June 30, 2022, Had About $204.3 Mln In Cash, Cash Equivalents & Investments

    Picture of POINT Biopharma Global logoPOINT Biopharma Global
    12/08/2022 13:54
    Aug 12 (Reuters) - POINT Biopharma Global Inc  PNT.O :
    * POINT BIOPHARMA REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS HIGHLIGHTS
    * POINT BIOPHARMA GLOBAL - AS OF JUNE 30, 2022, HAD ABOUT
$204.3
MILLION IN CASH, CASH EQUIVALENTS & INVESTMENTS, ANTICIPATED TO
FUND OPERATIONS INTO Q1 2024

Source text for Eikon:  ID:nGNXbtgbmV 
Further company coverage:  PNT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on POINT Biopharma Global

    See all news